As of Feb 18, 2025, HCA Healthcare, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $257.1. This suggests it may be overvalued by (18.8%) compared to its current price of around $316.5, using a WACC of 10.6% and growth rates of 3.0%.
As of Feb 18, 2025, HCA Healthcare, Inc.'s Weighted Average Cost of Capital (WACC) is approximately 10.6%.
As of Feb 18, 2025, HCA Healthcare, Inc.'s Enterprise Value (EV) is approximately $106.5B. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.